DsbA, a 21-kDa protein from Escherichia coli, is a potent oxidizing disulfide catalyst required for disulfide bond formation in secreted proteins. The active site of DsbA is similar to that of mammalian protein disulfide isomerases, and includes a reversible disulfide bond formed from cysteines separated by two residues (Cys30-Pro31-His32-Cys33).
The efficient introduction of disulfide bonds into newly translocated proteins in the periplasm of Escherichia coli is catalyzed by the redox protein DsbA (Bardwell et al., 1991 Akiyama et al., 1992) . In eukaryotes, the protein that catalyzes the equivalent reaction in the endoplasmic reticulum is protein disulfide isomerase (PDI) (Freedman, 1989) . Despite differences in size and complexity, DsbA (21 kDa) and PDI (2 X 57 kDa) both incorporate the thioredoxin fold in their structure. The PDI sequence has two thioredoxin oxidoreductase domains per monomer (Edman et al., 1985; Kemmink et al., 1996) and DsbA incorporates a single thioredoxin domain (with an additional helical domain inserted into the thioredoxin domain). The sequence identity between DsbA and thioredoxin is only about 10% (Martin et al., 1993a) . The redox active site of the thioredoxin domain in both proteins includes the characteristic Cys-X-X-Cys motif, in which the two cysteines can reversibly form a disulfide bond.
Reprint requests to: Jennifer L. Martin, Centre for Drug Design and Development. University of Queensland, Brisbane, QLD 4072, Australia; e-mail: J.Martin@mailbox.uq.oz.au. DsbA and PDI are both strong oxidants, which is reflected in their low redox equilibrium constants with glutathione (K,,r) of -0.1 mM (Wunderlich & Glockshuber, 1993b; Zapun et al., 1993) and -1 mM (Lundstrom & Holmgren, 1993; Darby & Creighton, 1995) , respectively. In contrast, the K,,, of the general protein reductant thioredoxin is 10 M (Lin & Kim, 1989) . The highly oxidizing nature of DsbA is critical for its disulfide catalysis function and has been postulated to be a result of the very low pK,, of Cys30, the more N-terminal of the two redox active-site cysteines (Nelson & Creighton, 1994; Grauschopf et al., 1995) . The usual pK,, value for a cysteine is -9, but that of DsbA Cys30 is 3.5 (Nelson & Creighton, 1994 ). The extremely low pK,, of DsbA makes it highly oxidizing by facilitating the exit from disulfide exchange reactions with Cys30 in the reduced thiolate ion form. Furthermore, the reduced form of the protein has been shown to be more stable than the disulfide-bonded form of DsbA (Wunderlich et al., 1993; Zapun et al., 1993) , in contrast to most protein disulfides that enhance protein stability.
The unusual properties of the DsbA active-site disulfide arise, at least in part, from the two amino acids between the cysteines of the active site. These two residues are characteristically different between thioredoxin-like redox protein families, yet are highly conserved within each family (thioredoxin Cys-Gly-Pro-Cys; glutaredoxin Cys-Pro-Qr-Cys; DsbA Cys-Pro-His-Cys; PDI CysGly-His-Cys). For example, by mutating the proline residue in thioredoxin to histidine (as in PDI) the redox potential is increased by 35 mV (Krause et al., 1991) to become more like that of PDI. Mutations between the cysteines in DsbA can result in redox equilibrium constants that differ by three orders of magnitude from that measured for wild-type (wt) DsbA (Grauschopf et al., 1995) .
Of prime importance in DsbA function and stability is the histidine residue, His32, between the two active-site cysteines. The properties of three His32 mutants-tyrosine, serine, and leucineare given in Table 1 . All three mutants are less oxidizing than wt DsbA as shown by the altered K,, values (which are increased 10-50 fold). In addition, there are large stability changes in the oxidized and reduced forms of the mutant enzymes compared with wt DsbA. For example, the single amino acid change that gives rise to H32Y, the glutaredoxin variant of DsbA, results in a reversal of the wt stability. Thus, in contrast to wt DsbA, the oxidized form of H32Y DsbA is the more stable of the two redox forms. Furthermore, the oxidized form of H32Y is significantly more stable (by 6.8 kcal/mol) than the oxidized form of the wt enzyme.
The other two His32 mutants were identified from an in vivo screen for DsbA mutants with altered redox activity (Grauschopf et ai., 1995) . Conversion of His32 to leucine (H32L DsbA) or serine (H32S DsbA) results in a protein with a significantly more stable oxidized form and a more stabilized reduced form. Although both oxidized and reduced forms are stabilized relative to the equivalent forms in wt DsbA, the oxidized form of both mutants is stabilized substantially more. This results in a smaller difference in stability between the oxidized and reduced forms (AAG) of the mutants compared with wt. This smaller AAG can be used to predict that these mutants should have a less oxidizing redox equilibrium constant than has wt DsbA. The measured redox equilibrium constants of these mutants follow this prediction.
The data from the present work show that, compared with other residue types, a histidine at position 32 in the sequence destabilizes the oxidized form of DsbA by -5-7 kcal/mol. This destabilization of oxidized DsbA by His32 could be a conformational effect, a change in solvent structure around the active-site, or an electrostatic effect. Based on our analysis of the crystal structures of the oxidized forms of three DsbA His32 mutants, it appears that an electrostatic effect is the most likely mechanism for destabilization of oxidized DsbA by histidine at position 32. 
Results

Structures of the oxidized His32 mutants of DsbA
The crystal structures of the three His32 DsbA mutants in the oxidized form have been determined to high resolution (Table 2) . These structures are isomorphous with the oxidized wt DsbA crystal structure allowing a direct comparison to be made between these structures.
For the comparison of the His32 mutant structures with wt DsbA, we used the structure of oxidized wt DsbA refined to 1.7 8, (Guddat et al. 1997 ; PDB accession code IFVK). This structure is similar to that refined to 2.0 8, (Martin et al., 1993a 
Analysis of the active-site disulfide
The active-site disulfide of DsbA is located at the N-terminal end of the first helix in the thioredoxin domain and comprises residues Cys30-Pro31-His32-Cys33. In this crystal form, the active-site cysteines are oxidized to form a disulfide, and the two monomers in the asymmetric unit are oriented such that the active sites face each other. As in all known structures of the thioredoxin family of disulfide oxidoreductases, the Cys30-Cys33 disulfide bridges in wt DsbA are right-handed for both monomers of the asymmetric unit. In wt DsbA, the ,yss values are 80" and 76" and the Ca-Ca distances are 5.1 A and 5.2 A, respectively.
The disulfide conformation of DsbA is one of the least populated in a study of disulfide bond conformation (three out of 43; Srinivasan et al., 1990) yet is highly conserved within the thioredoxin redox protein family. This could be a result of geometric restrictions imposed by disulfide bond formation between cysteines separated by only two residues (the number of intervening residues in the disulfides studied by Srinivasan et ai. varies from four to 129).
In all three His32 mutant DsbA structures, the disulfide bridge maintains the right-handed conformation of wt oxidized DsbA. The active-site atoms of residues 30-33 are identically placed to those in the wt structure, with r.m.s. deviations for all pairs of This structural equivalence between mutants with very different redox properties provides strong support for an electrostatic rather than a structural role of His32 in determining the redox properties of DsbA (see Discussion).
Confonnational analvsis of residue 32
As there was no significant change in DsbA structure in the His32 mutants, we examined in detail the conformation of the mutated residue 32. The conformational preference of amino acid side chains in proteins has been analyzed using high resolution protein crystal structures (McGregor et al., 1987; Ponder & Richards, 1987) .
Generally, three rotamers are found for the x1 angle of all amino acid side chains (defining the rotation about the Ccu-Cp bond), these being gauche-(g-, -60°), trans (t. -180") and gauche+ (g+, "60"). The preference for each rotamer varies depending on residue type and secondary structure. Analysis of the rotamer distribution for residues at the N-termini of helices (McGregor et al., 1987) is particularly useful for the investigation of residue 32 in DsbA, the mutated amino acid, since it is situated near the N-terminus of the al-helix (position N2 in the nomenclature of Richardson & Richardson, 1988) . In this context, a g+ conformation of residue 32 places the side chain into solvent, a t rotamer positions it near hydrophobic residues from the core of the protein, and a g-rotamer places it over the disulfide bond (Fig. 1) . Furthermore, rotation of residue 32 in monomer A is unrestricted around x1 (all three rotamers are possible). However, rotation of residue 32 of monomer B is restricted (the g+ rotamer is disallowed) due to steric constraints imposed by atoms from the noncrystallographic symmetry related monomer A (Fig. 1) .
Histidine residues near the N-termini of helices prefer to adopt the g+ rotamer (54%), although the t and g-rotamers are found in lower, but equal, proportion (23%) (McGregor et al., 1987) . His32 in the wt DsbA structure is observed in two conformations ( Fig. 2a ; Table 3 ): The unrestricted His A32 adopts the most favored g+ conformation and His B32 has the t conformation. The His A32 side chain points towards solvent, is poorly ordered, and makes interactions only with waters (Table 3) . Conversely, His B32 points into the protein, is shielded from bulk solvent by monomer A, is well-ordered, and is stabilized by hydrogen bonds to a symmetry-related protein atom and a water, and by interactions Fig. 1 . The three x1 side-chain rotamers of residue 32 in DsbA. The region around DsbA monomer B active site is shown. The three side-chain rotamers of residue 32 are g+ (light gray, pointing to the right), r (black, pointing down), and g-(dark gray, pointing to the left). The g+ conformation is accessible in monomer A but disallowed in monomer B because of steric constraints imposed by monomer A (dark gray). Residues shown from the active-site helix of monomer B are Cys30. Pro3 1, Tyr32, Cys33. Tyr34, (311135, Phe36, Glu37, Glu38, and Leu40 (Cys30, Tyr32. and Similar to the observation for histidines, a tyrosine residue at the N-terminal end of a helix is most likely to be found as the g+ rotamer (62%). However, of the remaining two rotamers, t (31%) is clearly preferred over g-(8%) (McGregor et al., 1987) . The structure of H32Y DsbA shows that the mutated residue Tyr32 is in the t conformation in both monomers ( Fig. 2b; Table 3 ). Thus, in the A monomer, where rotation of residue 32 is not enforced by crystal contacts, Tyr 32 adopts a different rotamer conformation to His 32.
The t conformation in this instance is probably adopted to minimize solvent accessibility of the tyrosine side chain. In both A and B monomers, the side chain of 51-32 forms no hydrogen bonds but the aromatic ring is stabilized by non-covalent interactions with Phe36 and Prol51. The side-chain accessible surface area of Tyr A32 and B32 is 83 and 16 A', respectively (Table 3) . When Tyr A32 is rotated into the g+ conformation, the side-chain accessible surface area is calculated to be 150 A' . Of the other 16 tyrosine residues in the DsbA crystal structure, the side-chain accessible surface area varies between 0 and 71 A'. Even in the more buried t conformation, Tyr A32 has a high average side-chain B-factor (50 A') compared with Tyr B32 (29 A') and compared with other tyrosine side-chains in the DsbA structure (21 -44 A'). Indeed, for all four DsbA structures, the side chain of residue 32 from monomer A has higher average B-factors and solvent accessibility than residue 32 from monomer B (which is shielded by monomer A).
The conformational preference of leucine residues at the N-termini of a-helices is roughly distributed between t (49%) and g+ (46%), with a much lower preference for g-(5%) (McGregor et al., 1987) . For H32L DsbA, residue 32 is found in the t conformation in both monomers (Fig. 2c) . As with H32Y, the preference for this rotamer is probably a result of hydrophobic stabilization.
Finally, serine residues are unusual in their preference for the g-conformation (65%) over the t and g+ conformations (18% each) at the N-termini of a-helices (McGregor et al., 1987) . For H32S DsbA, the unrestricted A conformation adopts the g+ conformation ( Fig. 2d; Table 3 ), like that of His32 in wt DsbA. In this conformation, the hydroxyl of the Ser A32 side chain interacts with a solvent molecule. The B conformation of Ser32 adopts the preferred g-conformation and interacts with a solvent molecule, and possibly also with Cys30 Sy (3.8 A) . The t conformation for the serine side chain at residue 32 in DsbA is probably least preferred because of the hydrophobic environment.
Solvent structure around the active site
Mutation of His32 could theoretically cause changes to the stability and redox properties of DsbA by altering the solvent structure around the active site. However, the solvent structure is remarkably well-conserved throughout these four structures. In the wt DsbA structure, there are two water molecules (Watl and Wat2; Fig. 3 ) located near the Sy atom of the accessible active-site residue Cys30. Watl is present in wt and all three His32 mutant DsbA structures, in both A and B monomers. It forms a hydrogen bond with the main-chain N of residue 32 (2.8-3.0 A), can interact with polar side chains of this residue (wt His32 and H32S), and also forms a hydrogen bond with Wat2 (2.7-3.0 A). Watl is 3.7-3.9 A distant from the Sy atom of Cys30, and its B-factor varies from 25-33 A'.
Wat2 is found in monomer B of all four structures, and in monomer A of H32S and H32L DsbA. It is positioned very near Sy of Cys30 (3.1-3.4 A). In two of the DsbA molecules (wt monomer B and H32S monomer A), Wat2 also forms hydrogen bonds with a third water (Wat3) and with the main-chain 0 of Val150 (Fig. 3) .
In all cases, the B-factor of Wat2 (34-48 A') is somewhat higher than for Watl indicating that it is not as well-ordered.
The remarkable similarity of the solvent structure around the active site in all four DsbA structures suggests that alteration in the solvent structure is not responsible for changes in the redox properties of DsbA.
Phe36
As described above, there are no major structural changes in going from wt DsbA to any of the His32 DsbA mutants. There are changes in some surface-exposed side chains. However, these changes are not correlated with any other structural or functional changes and probably represent the range of motion available to these solvent accessible side chains. The only example of a concerted structural change for a buried residue appears to be Phe36. This residue has been implicated in substrate binding since it forms part of the proposed peptide-binding groove of DsbA (Martin et al., 1993a ). Also, as described above, Phe36 can interact with residue 32 when the latter adopts the t conformation.
The movement in Phe 36 upon His32 mutation is relatively small, involving a x 1 rotation of up to 20" (Fig. 4) . The conformation of Phe36 is g+ in all these DsbA structures, although the observed values of x1 (-89" to -108") are somewhat removed from the preferred value (-60"). The small conformational changes in Phe36 are not a result of disorder, since the average side-chain B-factors are good (22-34 A'). Rather, the observed changes appear to be a response to the changes occumng at the mutation site. Thus, compared with Phe36 of wt His32 DsbA (x1 -99"), Phe36 of H32Y moves further away from the active site (x1 -105" to -108") to allow more room for the bulky Tyr32 side chain. Conversely, for the smaller side chains (Ser32, Leu32), Phe36 moves closer to the active site (x1 -89" to -94") compared with that in wt DsbA. While these changes show that this buried residue can adapt to different environments in its vicinity (presumably an important requirement for a residue in a peptide binding site), they do not sufficiently explain the large changes in stability observed for the oxidized form of DsbA.
Strained domain connection
There are two domains in the three-dimensional structure of DsbA-a thioredoxin domain and a helical domain that is inserted Fig 3. ( I ) . and gauche+ (x+) conformations. The specific angle is given in parentheses.
into the thioredoxin domain (Martin et a!., 1993a) . One of the two connections between the thioredoxin and helical domains of DsbA is a type IV /?-turn consisting of residues Phe63-Met64-Gly65-Gly66. The first residue of this turn, Phe63, has a strained mainchain conformation ( N-Ca-C -120") in the wt DsbA structure and has been postulated to be a hinge point for domain motion (Guddat et al. 1997) .
It was of interest to see whether the stability changes in the His32 mutants might be a result of the relief of strain in this "hinge" residue. However, all three His32 mutant structures retain the strained Phe63 main-chain conformation (1 20-1 23"). Thus, the stability differences between the oxidized form of wt DsbA and His32 mutants is not due to a relaxation of this main-chain angle. It is likely that our understanding of the functional importance, or otherwise, of the strained main chain of Phe63 will depend upon the structure determination of the reduced form of DsbA.
Discussion
Although the thermodynamic stabilities of the three oxidized His32 DsbA variants are increased markedly compared to the oxidized wt, the analysis of the high-resolution crystal structures reveals no large changes in structure compared with the wt protein. The structural changes observed appear to be restricted to local rearrangements in the vicinity of the exchanged residue. Similar results have been observed previously for other proteins (Clarke et al., 1995; Jackson et al., 1995; Matthews, 1995) . However, the oxidized DsbA variants H32Y. H32L. and H32S appear to be some of the most extreme examples known so far. The exchange of a single, surface-exposed residue stabilizes the oxidized protein by 5-7 kcal/ mol compared with oxidized wt DsbA. The only structural consequence of the mutation to tyrosine, leucine, or serine is a difference in population of three possible conformations of the mutated side chain and a small displacement of a nearby phenylalanine residue. Thus, significant shifts in the stability of a protein upon mutation of a residue may not be accompanied by large conformational differences.
The detailed conformational analysis of residue 32 (based on data from Table 3) shows that the hydrophobic residues tyrosine and leucine at this position prefer to adopt a conformation that minimizes solvent accessibility. The analysis also reveals that the polar histidine and serine side chains have distinct conformational differences between monomers A and B in this crystal form. Since the active site of monomer B is constrained by the presence of a nearby protein molecule (a non-crystallographic symmetry-related DsbA protein), this change in polar side chain conformation could represent a change that occurs upon interaction of DsbA with a protein substrate. The significance of such a conformational change is unclear but, at the least, the conformation observed in monomer B of wf DsbA may be required for substrate access to Cys30. Also, the DsbA mutant structures show that the stability changes resulting from His32 modification are not a result of an altered active-site structure, nor to a change in solvent structure at the active site. Thus, the precise structure of the active-site disulfide of DsbA is retained in the structures of the oxidized His32 mutants. Furthermore, two water molecules, which may be involved in stabilizing the catalytic Cys30 side chain, are highly conserved in the DsbA wf and His32 mutant structures. One of these waters interacts through a hydrogen bond with residue 32, yet is found in the DsbA structure whether residue 32 is a histidine, a tyrosine, a leucine, or a serine. The functional role, if any, of these waters is not known though both would probably need to be displaced to allow the formation of a mixed disulfide between DsbA and polypeptide substrate.
Overall, the structural results support the possibility that His32 destabilizes oxidized DsbA at pH 7, not through a conformational effect but through an electrostatic effect. A destabilizing electrostatic effect for the equivalent histidine in oxidized PDI has been proposed (Kortemme et al., 1996) . The important contributors at the active site to electrostatic differences between the oxidized and reduced states of DsbA and PDI appear to be the thiolate anion of Cys30, the partial positive charge generated at the N-terminus of the helix dipole ( Hol et al., 1978) , and the histidine situated between the two active-site cysteines. The Cys3O thiolate anion is present only in the reduced form of these proteins, while the helix dipole is likely to be a factor in both the reduced and oxidized forms. The pK, of His32 in oxidized DsbA is not known. However, the destabilizing effect of the equivalent histidine in oxidized PDI is observed as a lowered pK, (Kortemme et al., 1996) and this could also be true for His32 in DsbA. In reduced DsbA, the activesite histidine may be at least partially charged at physiological pH, through a favorable interaction with the thiolate anion of Cys30. The relative stability of reduced DsbA or PDI compared to their respective oxidized forms can thus be explained, at least in part, in terms of electrostatic stabilization of the Cys3O thiolate through favorable interaction with the partial positive charges of the helix dipole and possibly the active-site histidine in the reduced enzyme (Kortemme et al., 1996) and an unfavorable interaction between the histidine and the helix dipole in the oxidized enzyme.
In the oxidized form, replacement of His32 of DsbA with tyrosine, leucine, or serine results in an increase in stability of -5-7 kcal/mol (Table 1) compared with wf, oxidized DsbA, but there is no concomitant change in structure. The stabilization of the oxidized form is greatest when His32 is replaced with a tyrosine (H32Y) rather than with leucine (H32L) or serine (H32S). The higher stability of the oxidized glutaredoxin variant H32Y DsbA compared with the respective oxidized forms of the other His32 mutants could also be an electrostatic effect since tyrosine can be negatively charged, in principle, while leucine and serine cannot. A negatively charged tyrosine at position 32 could interact favorably with the partial positive charge of the helix dipole-an interaction that is not possible for the other two His32 mutants. Alternatively, the tyrosine at position 32 may be further stabilized compared with the other oxidized His32 mutants through the formation of favorable hydrophobic interactions with Phe36.
The crystal structures of these His32 mutants do not provide conclusive answers to the questions of stability and redox properties of DsbA, particularly in regard to the observed stability changes of the dithiol form. It is possible that a much clearer picture may emerge when the structure of reduced DsbA is known. However, the DsbA mutant structures do show that large conformational changes and changes in active-site solvent structure can be ruled out as possible mechanisms by which His32 destabilizes the oxidized form of wt DsbA. Consequently, the results presented here support the argument that active-site electrostatics play an important role in determining the stability and redox properties of DsbA.
Materials and methods
Measurement of redox equilibrium constants, Cys3O p K , and stability
The equilibrium constant between H32Y DsbA and glutathione was measured fluorimetrically using the redox state-dependent fluorescence of DsbA at 330 nm, assuming no significant equilibrium concentrations of DsbA/glutathione-mixed disulfides (Wunderlich & Glockshuber, 1993b) . The oxidized protein (1 pM) was incubated for 16 h at 30°C in 100 mM sodium phosphate pH 7.0, 1 mM EDTA containing 5-500 p M GSSG and 1-15000 p M GSH under nitrogen atmosphere. The true concentration of GSSG in each redox buffer was determined independently with the glutathione reductase assay as described previously (Loferer et al., 1995) . The equilibrium constants with glutathione (&J were determined by fitting the original fluorescence data according to Equation 1. where F is the measured fluorescence at 330 nm and F,, and Fred are the fluorescence intensities of the oxidized and reduced protein, respectively.
The pH-dependent ionization of the C30 thiol was followed at 30 "C by the specific absorbance of the thiolate at 240 nm (Nelson & Creighton, 1994; Grauschopf et al., 1995; Hennecke et al., 1997) . As a control, the pH-dependent absorbance of the oxidized form was recorded. To avoid precipitation artifacts and to minimize buffer absorbance, a buffer consisting of 10 mM K2HP04, 10 mM boric acid, 10 mM sodium succinate, 1 mM EDTA, and 200 mM KC1 (containing 100 p M P-mercaptoethanol for the reduced proteins) was used. The pH (initial value: 8.5) was lowered to 2.2 by stepwise addition of aliquots of 0.1 M HCI and the absorbance at 240 nm and 280 nm was recorded and corrected for the volume increase. Samples had an initial protein concentration of 25 pM. The pH-dependence of the thiolate-specific absorbance signal ([A240/A280]reduced/[A240/A280]oxidized) was fitted according to the Henderson-Hasselbach equation.
Stability measurements for H32Y DsbA are taken from Wunderlich (1994) . Stability measurements for H32S DsbA were performed as described in Grauschopf et al. (1995) . Redox equilibrium constants for wt DsbA H32S and H32L, and stability measurements and pK, of Cys30 for wt and H32L DsbA are taken from Grauschopf et al. (1995) . The Cys30 pK, value for H32S (P. Korber and J. C. A. Bardwell, unpublished) was measured as previously described for H32L Grauschopf et al. (1995) .
Protein production and crystallization
The DsbA variant H32Y was constructed by site-directed mutagenesis according to Kunkel (Kunkel et al., 1987) using singlestranded DNA from the expression plasmid pRBI-PDI (Wunderlich & Glockshuber, 1993a) , expressed and purified as described previously (Wunderlich et al., 1995) . The H32S and H32L mutants were identified from an in vivo screen for mutants of DsbA with altered redox activity and were prepared as described previously (Grauschopf et al., 1995) .
Samples for crystallization of all three His32 DsbA mutants were oxidized using 1.5 mh4 copper [I13 phenanthroline, dialyzed against 20 mM Hepes/NaOH pH 7.5, and purified by FPLC on a HR 5/5 Mono Q column followed by concentration to 20-40 mg/mL. Crystals of the DsbA mutants were grown using the same method used for wt DsbA crystals, and are isomorphous with the C2 form wt DsbA crystals (Martin et al., 1993b) 
Crystallographic data collection and processing
Statistics from the crystallographic data processing are presented in Table 2 . Data were measured at 16°C using an RAXIS-IIC imaging plate area detector with RU-200 rotating anode generator. The X-ray generator was operating at 60 kV and 90 mA for H32Y and at 46 kV and 60 mA for H32S and H32L. The crystal to detector distance was 100 mm for H32Y DsbA and 75 mm for H32S and H32L. An oscillation range of 3" was used for H32Y and 2" for H32S and H32L. The exposure time per frame was 30 min for H32Y and H32S, and 20 min for H32L. For H32Y, the frames were integrated, scaled, and merged using the package provided with the RAXIS-IIC system (Higashi, 1990) . Data frames for H32S and H32L were processed using DENZO and SCALEPACK (Z. Otwinowski and W. Minor).
Crystallographic refinement of H32 DsbA mutant structures
The coordinates of oxidized wt DsbA (refined at a resolution of 1.7 A (Guddat et al. 1997 ; PDB accession code IFVK) were used as the starting model for modeling the His32 mutant structures. Initially, the mutated residue 32 was modeled as alanine. Subsequent difference Fourier analysis clearly established the position of the side chain in all cases, and these side chains were then built into the structure. Model building was performed using 0 (Jones et al., 1991 ) and structural refinement was performed using X-PLOR v3.1 (Briinger, 1992b ). Positional refinement, individual B-factor refinement, and bulk solvent correction were employed for structure refinement, using standard X-PLOR protocols. Refinement statistics are given in Table 2 .
Residues modeled as alanine due to poorly defined side-chain density are: H32Y residues 13, 14, 52, and 148 from both monomers, residues 55 and 164 from monomer A, and residues 7, 47, and 132 from monomer B; H32L residues 13, 14,52,55, and 148 from both monomers, residues 7 and 164 from monomer A, and residues 47, 132, and 158 from monomer B; H32S residues 13, 14, 47,52,55, and 148 from both monomers, residue 7 from monomer A, and residue 132 from monomer B. Coordinates of H32Y DsbA, H32L DsbA, and H32S DsbA have been deposited with the Brookhaven Protein Data Bank (Bernstein et al., 1977) with accession codes IFVJ, lAC1, and IACV, respectively. Structure factors have also been deposited but will be held for release for four years. 
